- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Nanoemulsion.
Displaying page 1 of 1.
EudraCT Number: 2015-004111-20 | Sponsor Protocol Number: Q291dnro62/2015 | Start Date*: 2016-01-12 |
Sponsor Name:Janne Räsänen | ||
Full Title: Photodynamic therapy for Lentigo maligna with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) | ||
Medical condition: Lentigo maligna | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000624-37 | Sponsor Protocol Number: CLOBOF3-17IA03 | Start Date*: 2022-10-05 | ||||||||||||||||
Sponsor Name:Laboratorios Salvat, S.A. | ||||||||||||||||||
Full Title: A Phase 3, multicenter, randomized, evaluator-blinded clinical trial to assess the safety and efficacy of Clobetasol propionate ophthalmic nanoemulsion, 0.05% compared to Prednisolone acetate, 1% i... | ||||||||||||||||||
Medical condition: Inflammation and pain associated with ocular surgery. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000314-20 | Sponsor Protocol Number: ALA-AK-CT001 | Start Date*: 2006-09-26 | |||||||||||
Sponsor Name:Biofrontera Bioscience GmbH | |||||||||||||
Full Title: A randomized placebo-controlled clinical trial of topical photodynamic therapy with a nanoemulsion formulation of 5-aminolevulinic acid for the treatment of actinic keratosis | |||||||||||||
Medical condition: actinic keratosis (AK) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006854-24 | Sponsor Protocol Number: ALA-AK-CT002 | Start Date*: 2008-04-17 | |||||||||||
Sponsor Name:Biofrontera Bioscience GmbH | |||||||||||||
Full Title: A randomized, observer blind, multinational phase III study to evaluate the safety and efficacy of a nanoemulsion gel formulation BF-200 ALA, in comparison with Metvix® and placebo, for the treatme... | |||||||||||||
Medical condition: Actinic keratosis (AK) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) AT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003371-39 | Sponsor Protocol Number: ALA-AK-CT003 | Start Date*: 2007-12-04 | |||||||||||
Sponsor Name:Biofrontera Bioscience GmbH | |||||||||||||
Full Title: A randomized, double-blind, phase III multicenter study evaluating the safety and efficacy of BF-200 ALA versus placebo in the treatment of actinic keratosis when using PDT | |||||||||||||
Medical condition: actinic keratosis (AK) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003241-42 | Sponsor Protocol Number: ALA-BCC-CT008 | Start Date*: 2013-12-23 | |||||||||||
Sponsor Name:Biofrontera Bioscience GmbH | |||||||||||||
Full Title: A randomized, observer blind, multinational phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) in comparison to Metvix® in the treatment of non-aggressive basal cell carcin... | |||||||||||||
Medical condition: Basal cell carcinoma (BCC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
